Pharma trailer - The video gives a glimpse into its plot as well as rest of the characters in this series, which will be ...

All India Pharmacy Students Rights Forum (PSRF), All India Drug Control Officers’ Confederation (AIDCOC) and several other organisations and experts in the field of pharmacy have long been demanding ...

The Defence Research & Development Organization (DRDO) conducts the DRDO CEPTAM Exam 2025 for various technical posts. Candidates should know the syllabus to start preparation effectively. It helps ...

The UK is losing out to competitors in attracting investment in R&D, clinical trials, and capital projects due to a stubborn refusal to pay for innovative new medicines, according to the pharma ...

India's pharmaceutical industry must shift towards innovation in complex generics, including peptides, biosimilars, and ...

PHARMEXCIL urges pharma industry to transition to innovation, complex generics, and R&D for global leadership. Focus on ...

NEW DELHI: The Centre has extended the deadline for applying for the ₹5,000-crore Promotion of Research and Innovation in Pharma & MedTech (PRIP) Scheme, planned to facilitate wider participation and ...

Tokyo, Japan and Cambridge, UK, 4 November 2025 – Nxera Pharma Co., Ltd. (“Nxera”; TSE: 4565) a technology-powered biopharmaceutical company, today announces that it will hold an R&D Day on 18 ...

This story was originally published on PharmaVoice. To receive daily news and insights, subscribe to our free daily PharmaVoice newsletter. Three of the top four AI companies by market capitalization ...

In 2023, Johnson & Johnson announced it had stopped research and development on therapeutics for many infectious diseases, including hepatitis and tuberculosis. Less visibly, AbbVie shuttered last ...

In an effort to drive innovation in domestic pharma sector, the government is seeking applications for a scheme with an outlay of Rs 5,000 crore (around $600 million) over next five years, to shift ...

European pharmaceutical stocks traded sharply higher after President Trump unveiled plans to launch a drug-buying website for consumers and a pricing deal with Pfizer, in a move that analysts say ...